Porton Advanced Congratulates Esteemed Partner Lion TCR on IND Approval from NMPA for mRNA TCR-T Cell Therapy GZL-016 in Hepatitis B-Related Liver Cancer
We are thrilled to announce that this week, our esteemed partner Lion TCR has achieved…
Porton Advanced and Geneseed Biotech Enter into Strategic Collaboration to Focus on Advancing circRNA Innovative Therapeutics
On July 29, 2024, Porton Advanced Solutions (“Porton Advanced”) announced that it had reached a…
Porton Advanced introduces the MaxCyte ExPERT GTx Flow Electroporation instrument, continuing to provide customers with end-to-end cell and gene therapy CRO & CDMO services
Porton Advanced recently introduced the MaxCyte cGMP-grade ExPERT GTx Flow Electroporation instrument to its cell…
Porton Advanced and BRL Medicine Build Strategic Partnership to Accelerate Commercialization of Gene and Cell Therapies
On September 13th, 2023, Porton Advanced Solutions (Porton Advanced) announced a strategic partnership with…
Porton Advanced and Bennu Biotherapeutics Announced a Strategic Partnership to Accelerate cell engineering Development for Solid Tumors
Porton Advanced and Bennu Biotherapeutics Announced a Strategic Partnership to Accelerate cell engineering Development for…
Porton Advanced Collaborates with DanausGT to Accelerate the Development of Gene and cell engineering
Porton Advanced Collaborates with DanausGT to Accelerate the Development of Gene and cell engineering SUZHOU,China, March…
Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform
Porton Advanced will continue to advance its technology and capabilities to accelerate the development of…
Porton Advanced announced strategic cooperation with KAEDI to accelerate the R&D and production of CAR-T drugs
Dr. Hongjiu Dai, Chairman and CEO of KAEDI, said: “We are very pleased to have…
Porton Advanced and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate cell engineering Development for Solid Tumors
22 April 2022 – Suzhou Porton Advanced Solutions Ltd. (‘Porton Advanced’) and Guizhou Sinorda Biomedicine…